ALLAKOS INC.

• SAN CARLOS, CA How do I update this listing?

Allakos is based out of San Carlos. Allakos Inc. operates as a clinical stage bio-technology company. The Company discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory, and proliferative diseases. Allakos serves customers in the United States. The firm last filed a Form D notice of exempt offering of securities on 2017-12-18. The notice included securities offered of Equity

Contact Info

allakos inc.
825 INDUSTRIAL ROAD
SAN CARLOS CA 94070
Business Phone: 650-597-5002

SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date	Form Type	Industry Group	Securities Offered	Total Offering Amount	Total Amount Sold	Total Remaining
2017-12-18	D	BIOTECHNOLOGY	Equity	100,141,456	100,141,456	0
2015-03-25	D/A	PHARMACEUTICALS	Equity	47,000,008	27,949,545	19,050,463
2014-08-27	D/A	PHARMACEUTICALS	Equity	41,999,994	24,545,452	17,454,542
2012-12-20	D	PHARMACEUTICALS	Equity	31,999,989	9,999,997	21,999,992

Other Issuers in Filings
Name	Address
No Other Issuers

Related Parties included in filings
Name	Address	Relationship
CHRISTOPHER BEBBINGTON	subscription required	EXECUTIVE OFFICER DIRECTOR
NENAD TOMASEVIC	subscription required	EXECUTIVE OFFICER
ROBERT ALEXANDER	subscription required	DIRECTOR
JOHN MCKEARN	subscription required	DIRECTOR
PETER MOLDT	subscription required	DIRECTOR
FARAH CHAMPSI	subscription required	DIRECTOR
ALEJANDRO DORENBAUM	subscription required	EXECUTIVE OFFICER
ADAM TOMASI	subscription required	EXECUTIVE OFFICER
PAUL WALKER	subscription required	DIRECTOR
DAN JANNEY	subscription required	DIRECTOR
STEVE JAMES	subscription required	DIRECTOR